ANALYSIS OF DOSE INTENSITY IN DOXORUBICIN-CONTAINING ADJUVANT CHEMOTHERAPY IN STAGE-II AND STAGE-III BREAST-CARCINOMA

被引：36

作者：

ANG, PT

BUZDAR, AU

SMITH, TL

KAU, S

HORTOBAGYI, GN

机构：

[1] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST,CTR CANC, DEPT MED ONCOL,BOX 78,1515 HOLCOMBE BLVD, HOUSTON, TX 77030 USA

[2] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT BIOMATH, HOUSTON, TX 77030 USA

来源：

关键词：

D O I：

10.1200/JCO.1989.7.11.1677

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1677 / 1684

页数：8

共 17 条

[1] DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
BONADONNA, G
VALAGUSSA, P
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) : 10 - 15
[2] POST-OPERATIVE ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND BCG VACCINE - FOLLOW-UP REPORT
BUZDAR, AU
BLUMENSCHEIN, GR
GUTTERMAN, JU
TASHIMA, CK
HORTOBAGYI, GN
SMITH, TL
CAMPOS, LT
WHEELER, WL
HERSH, EM
FREIREICH, EJ
GEHAN, EA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (14): : 1509 - 1513
[3] BUZDAR AU, 1988, CANCER, V62, P2098, DOI 10.1002/1097-0142(19881115)62:10<2098::AID-CNCR2820621005>3.0.CO
[4] 2-B
[5] BUZDAR AU, 1984, CANCER, V53, P384, DOI 10.1002/1097-0142(19840201)53:3<384::AID-CNCR2820530303>3.0.CO
[6] 2-G
[7] COX DR, 1972, J R STAT SOC B, V34, P187
[8] TIME-DOSE FACTORS IN CHEMOTHERAPY - EXPANDING THE CONCEPT OF DOSE-INTENSITY
DEMBO, AJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 694 - 696
[9] GOODYEAR M, 1985, P AN M AM SOC CLIN, V4, P61
[10] MEASUREMENT OF DRUG-DOSAGE INTENSITY IN MVPP THERAPY IN HODGKINS-DISEASE
GREEN, JA
DAWSON, AA
FELL, LF
MURRAY, S
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (05) : 511 - 514